Skip to content

Effect of test food consumption on postprandial blood glucose levels in healthy subjects

Effect of test food consumption on postprandial blood glucose levels in healthy subjects - Effect of test food consumption on postprandial blood glucose levels in healthy subjects

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000058907
Enrollment
21
Registered
2025-09-01
Start date
2025-09-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy subjects

Interventions

Single intake of active food - Washout period - Non-intake Non-intake - Washout period - Single intake of active food

Sponsors

Other
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Japanese male and female subjects between the ages of 20 and 65 at the time of written consent. 2.Subjects who are blood glucose levels are within the normal range (less than 126 mg/dL at fasting) at the time of health chack up. 3. Subjects who have received a full explanation of the purpose and content of the study, have the ability to consent, understand the study well, and have volunteered to participate in the study and have agreed to participate in the study in writing.

Exclusion criteria

Exclusion criteria: 1.Subjects who are taking medication or under medical treatment. 2.Subjects who are under exercise therapy or dietetic therapy. 3.Subjects who have developed allergies as for the foods test. 4.Subjects with current or history of drug dependence or alcohol dependence. 5.Subjects who are hospitalized for mental disorders (depression, etc.) or sleep disorders(insomnia, sleep apnea, etc.), or have a history of mental disorders in the past. 6.Subjects with irregular life rhythms due to night shifts or shift work. 7.Subjects with extremely irregular lifestyle habits such as eating and sleeping. 8.Subjects who have an extremely unbalanced diet. 9.Subjects who have or have had serious diseases such as brain diseases, malignant tumors, immune diseases, diabetes, diabetes mellitus, liver diseases (hepatitis), kidney diseases, heart diseases, etc., thyroid diseases, adrenal diseases, and other metabolic diseases. 10.Subjects with a body mass index (BMI) exceeding 30. 11.Subjects who use health foods and medicines that contain ingredients that affect the trial 12.Subjects who have participated in other clinical trials (research) within 3 months retrospectively from the date of obtaining consent, or those who have plans to participate in other clinical trials (research) during the study period. 13.Subjects who have collected more than 200 mL of blood within 1 month or 400 mL within 3 months prior to the date of obtaining consent. 14.Subjects who are currently pregnant or breastfeeding. or who are likely to become so during the study period. 15.Subjects who are judged to be inappropriate as subjects based on clinical laboratory test values and measured values at the time of SCR. 16.Subjects who are considered as an inappropriate candidate by the doctor in charge.

Design outcomes

Primary

MeasureTime frame
blood glucose levels The incremental area under the curve for postprandial blood glucose levels(iAUC)

Countries

Japan

Contacts

Public ContactNatsuna Takezawa

Japan Frito-Lay Ltd. Development Division, M&S Headquarters

n.takezawa@fritolay.co.jp07048407264

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026